These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 30796165)

  • 1. Early Phase I Study of a
    Xing Y; Chand G; Liu C; Cook GJR; O'Doherty J; Zhao L; Wong NCL; Meszaros LK; Ting HH; Zhao J
    J Nucl Med; 2019 Sep; 60(9):1213-1220. PubMed ID: 30796165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive Imaging of Tumor PD-L1 Expression Using [
    Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J
    Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-rater and intra-rater agreement of [
    Hughes DJ; Chand G; Johnson J; Bailey D; Adamson K; Goh V; Cook GJR
    EJNMMI Res; 2023 May; 13(1):51. PubMed ID: 37256434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter- and intraobserver agreement of the quantitative assessment of [
    Hughes DJ; Chand G; Goh V; Cook GJR
    EJNMMI Res; 2020 Dec; 10(1):145. PubMed ID: 33259032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer.
    Smit J; Borm FJ; Niemeijer AN; Huisman MC; Hoekstra OS; Boellaard R; Oprea-Lager DE; Vugts DJ; van Dongen GAMS; de Wit-van der Veen BJ; Thunnissen E; Smit EF; de Langen AJ
    J Nucl Med; 2022 May; 63(5):686-693. PubMed ID: 34385342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-Humans Evaluation of a PD-L1-Binding Peptide PET Radiotracer in Non-Small Cell Lung Cancer Patients.
    Zhou X; Jiang J; Yang X; Liu T; Ding J; Nimmagadda S; Pomper MG; Zhu H; Zhao J; Yang Z; Li N
    J Nucl Med; 2022 Apr; 63(4):536-542. PubMed ID: 34326125
    [No Abstract]   [Full Text] [Related]  

  • 7. Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8
    Ertveldt T; Meulewaeter S; De Vlaeminck Y; Olarte O; Broos K; Van Calenbergh S; Bourgeois S; Deprez J; Heremans Y; Goyvaerts C; Staels W; De Smedt S; Dewitte H; Devoogdt N; Keyaerts M; Verbeke R; Barbé K; Lentacker I; Breckpot K
    Theranostics; 2023; 13(15):5483-5500. PubMed ID: 37908728
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical evaluation and pilot clinical study of [
    Ma X; Zhou X; Hu B; Li X; Yao M; Li L; Qin X; Li D; Yao Y; Hou X; Liu S; Chen Y; Wang Z; Zhou W; Li N; Zhu H; Jia B; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3838-3850. PubMed ID: 37555904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation Dosimetry of
    Urbán S; Meyer C; Dahlbom M; Farkas I; Sipka G; Besenyi Z; Czernin J; Calais J; Pávics L
    J Nucl Med; 2021 Aug; 62(8):1075-1081. PubMed ID: 33277398
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of
    Niemeijer AN; Oprea-Lager DE; Huisman MC; Hoekstra OS; Boellaard R; de Wit-van der Veen BJ; Bahce I; Vugts DJ; van Dongen GAMS; Thunnissen E; Smit EF; de Langen AJ
    J Nucl Med; 2022 Mar; 63(3):362-367. PubMed ID: 34272316
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Hu B; Chen W; Zhang Y; Shi H; Cheng D; Xiu Y
    Ann Nucl Med; 2020 May; 34(5):322-328. PubMed ID: 32130663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
    Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
    Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
    Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical development and characterisation of
    Wong NC; Cai Y; Meszaros LK; Biersack HJ; Cook GJ; Ting HH; Mottaghy FM
    Am J Nucl Med Mol Imaging; 2021; 11(3):154-166. PubMed ID: 34234994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on
    Takada K; Toyokawa G; Okamoto T; Baba S; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Honda H; Oda Y; Maehara Y
    Cancer Med; 2017 Nov; 6(11):2552-2561. PubMed ID: 28980429
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Cheng Y; Shi D; Xu Z; Gao Z; Si Z; Zhao Y; Ye R; Fu Z; Fu W; Yang T; Xiu Y; Lin Q; Cheng D
    Mol Pharm; 2022 Oct; 19(10):3551-3562. PubMed ID: 35244407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy.
    Gao H; Wu Y; Shi J; Zhang X; Liu T; Hu B; Jia B; Wan Y; Liu Z; Wang F
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a
    Zhao L; Liu C; Xing Y; He J; O'Doherty J; Huang W; Zhao J
    Mol Pharm; 2021 Sep; 18(9):3616-3622. PubMed ID: 34328338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, Characterization, and Radiation Dosimetry Studies of
    Kim J; Donnelly DJ; Tran T; Pena A; Shorts AO; Petrone TV; Zhang Y; Boy KM; Scola PM; Tenney DJ; Poss MA; Soars MG; Bonacorsi SJ; Cole EL; Grootendorst DJ; Chow PL; Meanwell NA; Du S
    Mol Imaging Biol; 2024 Apr; 26(2):301-309. PubMed ID: 38123744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry estimation and preliminary clinical application of [
    Yang H; Gao Z; Xu X; Liu C; Hu S; Zhang J; Song S
    Ann Nucl Med; 2023 Jan; 37(1):60-69. PubMed ID: 36346503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.